ArticleOncotarget2018

A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer.

Hatem Soliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.